Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) - Concepedia

Concepedia

Publication | Open Access

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

DOI Full Paper Access

150

Citations

30

References

2021

Year

Michael J. Wagner, Megan Othus, Sandip Pravin Patel, Chris Ryan, Ashish Sangal, Benjamin Powers, G. Thomas Budd, Adrienne I. Victor, Chung-Tsen Hsueh, Rashmi Chugh,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02834013.

References

	Year	Citations

Page 1